It is a pharma private limited company based in Bharaniputtur, Chennai-101, Tamil Nadu, India, established in 2005.
2005 | Bharaniputtur, Chennai-101, Tamil Nadu, India | ActiveMedline Pharmaceuticals Private Limited, a active private limited company, was established on 21 July 2005 in Bharaniputtur, Chennai-101, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN2005PTC057023. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.84 M.
It upholds a compliant status. Its leadership includes Raju Sundararaman (Director), Boominathan Nambi Narayana (Director). Past directors included Sathiyabama Boominathan. It holds ₹1.09 Cr open charges and ₹4.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot Ii And Iii, Ist Mmain Road E.V.P.Prabhu Avenu3E, Chinakolathuvanche, Rry, Bharaniputtur, Chennai-101, Tamil Nadu.
U24231TN2005PTC057023
057023
21 July 2005
₹1.00 M
₹0.84 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Medline Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raju Sundararaman | Director | 21 Jul 2005 | Current |
| Boominathan Nambi Narayana | Director | 21 Mar 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Mar 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medline Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.52% decrease. The company also saw a substantial improvement in profitability, with a 114.5% increase in profit. The company's net worth moved up by a moderate rise of 7.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Medline Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,900,000.00
₹4,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2016 | Others | ₹1.09 Cr | Open |
| 16 May 2007 | State Bank Of India | ₹4.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medline Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medline Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medline Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medline Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Medline Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
A charge with Others of Rs. 10.90 M registered on 04 Jul 2016 with Charge ID 100054411 was modified on 22 Sep 2020. was recorded as a recent event.
Progress on A charge registered on 16 May 2007 via Charge ID 10056608 with State Bank Of India was fully satisfied on 15 Sep 2016. was documented.
Progress on A charge with Others amounted to Rs. 10.90 M with Charge ID 100054411 was registered on 04 Jul 2016. was documented.
Progress on Boominathan Nambi Narayana was appointed as a Director was appointed as a Director on 21 Mar 2013 & has been associated with this company since 12 years 9 months . was documented.
The CIN of Medline Pharmaceuticals Private Limited is U24231TN2005PTC057023.
Medline Pharmaceuticals Private Limited is headquartered at Plot Ii And Iii, Ist Mmain Road E.V.P.Prabhu Avenu3E, Chinakolathuvanche, Rry, Bharaniputtur, Chennai-101, Tamil Nadu.
Medline Pharmaceuticals Private Limited was incorporated on 21 July 2005.
The current directors of Medline Pharmaceuticals Private Limited are
The primary industry of Medline Pharmaceuticals Private Limited is Manufacturing.
Medline Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medline Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.84 M.
The compliance status of Medline Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX